TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: incidence of intra-procedural food-related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of identifying AOIs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Easy categorization of radiographic AOIs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean time to change PCA pump settings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LLL at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TLR rate at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MAE occurrence at 12 months
Endpoint domain: Adverse events/effects
Primary endpoint: Maternal serum IGFBP-1 concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: docetaxel area under the plasma concentration–time curve (AUC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum concentration (Cmax) of docetaxel
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cmax of ritonavir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increases in alcohol-related knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: increases in cannabis-related knowledge
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: odds of drinking a full standard drink
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metabolic adaptation (RMR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Swedish Healthy Eating Index scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of postoperative desaturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Proportion of evidence-based prevention and screening actions achieved
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of HbA1c at week 16
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: mean dice similarity coefficient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: volumetric similarity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: success rate of bowel preparation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cup and stem angle accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: ESSPRI (oral dryness domain)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GLDH as a specific biomarker for liver injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: post-CPB thrombin generation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: higher satisfaction with hospitalization
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Increase in blood donations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of CRBSI
Endpoint domain: Adverse events/effects
Primary endpoint: Augmented pressure (AIx)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to Progression of Pain (TTPP)
Endpoint domain: Mortality/survival
Primary endpoint: Likelihood of compliance with public health guidelines
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Psychiatric hospitalization
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement of Range of Motion (ROM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fonseca's questionnaire score improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Usefulness of Specialist LINK
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Usefulness of PCN Clinical Pathways
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ANGPTL3 levels reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Eradication rates of Helicobacter Pylori
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Neonatal Infants Pain Scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean change in PTSD score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SAR risk reduction following accidental exposure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction in severity of hemoptysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incident Chronic Kidney Disease (CKD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Peak relative work rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Running velocity at various blood lactate concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of ARIA-edema (ARIA-E)
Endpoint domain: Adverse events/effects
Primary endpoint: presence of uncontrolled symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urine increase (mL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: B-type natriuretic peptide (BNP) reduction (pg/mL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Kyphosis maintenance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in lordosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gait speed maintenance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 50% reduction in symptom score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: KCCQ-12 score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: onset time of neuromuscular blockade
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gained 15 or more ETDRS letters in BCVA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean reductions in CST from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Satisfaction with the intervention
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in challenge appraisals
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Increases in coping skills
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: persistence of HPV infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: progression from baseline cytology
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Syndecan-1 concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Symptoms reduction
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: puncture time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical status at 14 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: knee function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: mean absolute error in surgical case duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean reduction of patient wait time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: mean time spent in facility before surgery
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: PTG (Post-Traumatic Growth)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: proportion of infants with malnutrition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: WAZ score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: HAZ, WAZ, and WHZ scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of medication-related harms
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of preventable medication-related harms
Endpoint domain: Adverse events/effects
Primary endpoint: Hospitalisation rate due to medication-related harms
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: 24 h postoperative morphine consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: subsyndromal depressive symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RP increase in the theta band
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: RP decreases in the beta bands
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: EEG coherences decreases in beta2, beta1 and gamma bands
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of postoperative pulmonary complications (POPCs)
Endpoint domain: Adverse events/effects
Primary endpoint: Extubating time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Myasthenia Gravis Activities of Daily Living total scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Myasthenia Gravis Foundation of America post‐intervention status of minimal manifestations
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Satisfaction VAS score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Cough VAS score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient-rated faces pain scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: self-reported levels of sleepiness
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Mean calcification size decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline CMS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relative activation time of core muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: difficulty maintaining sleep
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: early morning awakening
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Deaths attributed to COVID-19
Endpoint domain: Mortality/survival
Primary endpoint: Rate of participants with adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Pulmonary Artery Diastolic Pressure (PADP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: α-tocopherol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: γ-tocopherol isoform levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: β-carotene levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: severe or BG-confirmed hypoglycaemia
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical learning level
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Short Physical Performance Battery (SPPB) score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gait speed change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: risk of liver injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correct diagnosis accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Awareness of praziquantel
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Knowledge about the safety of praziquantel
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Seeking praziquantel treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of patients alive without disease progression at 12 months
Endpoint domain: Mortality/survival
Primary endpoint: Percentage of patients alive at 12 months
Endpoint domain: Mortality/survival
Primary endpoint: Overall response rate (complete or partial response)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: quality of SDM
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: patient decision making
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Weight loss (≥5% of baseline body weight)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stress level (Visual Analogue Scale)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Completion of intervention
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: KOOS score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Responder rate at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: learning performance during retention tests
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Breast conservation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Deep vein thromboembolism (DVT) after knee arthroplasty
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Serum NETs levels at 1 and 3 days after operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sVCAM‐1 levels at 1 and 3 days after operation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Abstinence at 6-month follow-up
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Time to first drink after relapse
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Alcohol-related self-efficacy at 6 months
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: caregiver satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: tract-related complications
Endpoint domain: Adverse events/effects
Primary endpoint: incremental QALY-AUC
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: incremental QALY-CFB
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: incremental QALY-MID
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Prevalence of neonatal hypothermia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Trait anxiety reduction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: S-specific binding antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: First postoperative walking time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative mean VAS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rehospitalization rates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Multidimensional Prognostic Index scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Taste and tolerability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bowel Preparation Quality Scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: frequency of ecchymosis
Endpoint domain: Adverse events/effects
Primary endpoint: frequency of hematoma
Endpoint domain: Adverse events/effects
Primary endpoint: frequency of severe lower back pain
Endpoint domain: Adverse events/effects
Primary endpoint: frequency of oozing
Endpoint domain: Adverse events/effects
Primary endpoint: Worsening of fibrosis on high-resolution computed tomography
Endpoint domain: Adverse events/effects
Primary endpoint: IPF exacerbation/or progression
Endpoint domain: Adverse events/effects
Primary endpoint: Serious AEs including deaths
Endpoint domain: Adverse events/effects
Primary endpoint: Exposure to lidocaine in subcutaneous tissue and plasma
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Health outcomes improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: EQ‐5D‐5L (self-care and mobility)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: TUG-cognitive (Timed Up and Go cognitive)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective anxiety levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Efficacy and safety of phytoconstituents in treating epilepsy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median patency time of stents
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 5 hr incremental area under the curve for postprandial glycaemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: reaction time in pronoun processing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Glucose incremental Area under the Curve (iAUC180)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Insulin incremental Area under the Curve (iAUC180)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Permanent stoma development
Endpoint domain: Adverse events/effects
Primary endpoint: need for invasive mechanical ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: engagement of and outcomes for intervention participants
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: patient and family outcomes
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Consecutive days of amenorrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total days of no bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of adverse events postdelivery
Endpoint domain: Adverse events/effects
Primary endpoint: Small for Gestational Age (SGA) births
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: 3-month body weight change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Aesthetic outcome (contour symmetry)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction score (PSS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Total operative time
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: average gain of bone height
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: thickness of trabeculae
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentric peak velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reactive strength index-modified (RSImod)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pre-dialysis sK+ concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: potassium gradient
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Postoperative Delirium (POD)
Endpoint domain: Mortality/survival
Primary endpoint: Likelihood of relapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Success rate (achievement of mean leak in the range 10%-20%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean percentage time within target leak range
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reintubations to optimise size
Endpoint domain: Adverse events/effects
Primary endpoint: VAS values for pain during injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of action of anesthetic solutions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: body positioning time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Relapse-Free Interval (RFI)
Endpoint domain: Mortality/survival
Primary endpoint: Progression-Free Cancer-Specific Survival (prCSS)
Endpoint domain: Mortality/survival
Primary endpoint: minutes in moderate-to-vigorous PA for adults
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative nasal airflow improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient satisfaction after rhinoplasty
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: risk of hospital admissions
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Increased course engagement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status